ReviewChildren (Basel, Switzerland)2026
Congenital Chest Wall Deformities in Children: A Narrative Review.
Review in Children (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital chest wall deformities encompass a broad spectrum of anomalies, from the common pectus excavatum and pectus carinatum to rare, life-threatening conditions such as sternal clefts, ectopia cordis, pentalogy of Cantrell, and asphyxiating thoracic dystrophy (Jeune syndrome). This narrative review synthesizes current evidence on their epidemiology and pathogenesis, genetics and syndromic associations, diagnostic assessment, and the full range of conservative and surgical management, with particular attention to developments of the past decade. Pectus deformities affect roughly 1% of children, and although familial clustering supports a genetic contribution, no single causative gene has been established; syndromic associations, especially connective-tissue disorders, remain clinically actionable and warrant cardiovascular surveillance. Conservative treatment has become first-line for suitable patients: the vacuum bell for pectus excavatum and dynamic compression bracing for pectus carinatum both achieve good results when compliance is maintained. Minimally invasive repair remains the surgical standard for pectus excavatum, complemented by the modified Ravitch and hybrid procedures for complex morphology, while emerging innovations and enhanced-recovery protocols continue to improve safety and recovery. The rarer midline and chondrodysplastic deformities demand individualized, often emergency, multidisciplinary care. Across the spectrum, the most reproducible benefit of treatment lies in body image, self-esteem and quality of life, whereas a generalizable cardiopulmonary benefit remains unproven. Management should be individualized to the deformity, the child's physiology, and the psychosocial burden of disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.